Resource Center
Resource Center
On Nov. 15, 2021 CHAI, MedAccess, and SD Biosensor announced a partnership to increase access to rapid diagnostic tests for syphilis and HIV.
Read moreThis report helps donors and buyers in public health better understand the offerings of respiratory equipment suppliers based in sub-Saharan Africa.
Read moreThe strawberry-flavored formulation of the WHO’s recommended first-line treatment for HIV is designed to overcome many of the barriers that stop young children taking their medication properly.
Read moreIntroducing the fifth edition of CHAI’s HIV Mid-Year Market Memo, a brief that covers the latest trends in the HIV space in low- and middle-income countries since the publication of CHAI’s annual HIV Market Report in September 2020.
Read moreThe expanded partnership will increase access to leading-edge cancer treatments in low- and middle-income countries including biologics and hormonal therapies.
Read moreIn 2019, CHAI launched our cervical cancer program with support from Unitaid. We partnered with governments in seven low-and-middle income countries to scale up safe, effective, and affordable pre-cancer screening and treatment technologies and assist partner governments in achieving global cervical cancer elimination targets, aiming to reduce the rate of premature mortality from the disease by a third.
Read moreA new study published in the Journal of the International AIDS Society highlights a CHAI-led project in seven sub-Saharan African countries to evaluate near-point-of-care (near-POC) tests used to monitor HIV viral load.
Read morePATH and CHAI, together with the Every Breath Counts coalition, have partnered on the COVID-19 Respiratory Care Response Coordination project to address the lack of oxygen access in several low- and middle-income countries.
Read moreThe report looks at the complex, ever-changing antiretroviral and diagnostic markets in low- and middle-income countries based on aggregated market intelligence from our programmatic work in over 30 countries.
Read moreAgreement with Omega Diagnostics will help deliver same-day CD4 testing for people living with HIV in over 130 low- and middle-income countries at just US$3.98 per test.
Read more